Invention Grant
- Patent Title: Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
- Patent Title (中): 用于靶向治疗癌症突变逃逸的靶向消融的组合物和方法
-
Application No.: US12531876Application Date: 2008-01-17
-
Publication No.: US08501167B2Publication Date: 2013-08-06
- Inventor: David Apelian , Alex Franzusoff , Timothy C. Rodell
- Applicant: David Apelian , Alex Franzusoff , Timothy C. Rodell
- Applicant Address: US CO Louisville
- Assignee: GlobeImmune, Inc.
- Current Assignee: GlobeImmune, Inc.
- Current Assignee Address: US CO Louisville
- Agency: Sheridan Ross P.C.
- Agent Angela Dallas Sebor
- International Application: PCT/US2008/051348 WO 20080117
- International Announcement: WO2008/115610 WO 20080925
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K31/131 ; A61K31/136 ; A61K31/166 ; A61K31/167
Abstract:
Provided herein are compositions and methods for targeted ablation of mutational escape in the face of cancer therapeutic agents. Compositions comprising the yeast-based vehicles are used in combination with other cancer therapeutic agents.
Public/Granted literature
- US20100111912A1 COMPOSITIONS AND METHODS FOR TARGETED ABLATION OF MUTATIONAL ESCAPE OF TARGETED THERAPIES FOR CANCER Public/Granted day:2010-05-06
Information query
